Sign inJoin waitlistJoin the waitlist

Jason Bacharach

Chief Resident, PGY-3

Credentials: · ·

History

Sutter Health
PGY-32024–Present
2024–Present
Sutter Health
2023–2024
HAHNEMANN MED COLL OF THE PACIFIC, SAN FRANCISCO
1980–1984

Research

Initial clinical experience with the Ahmed Glaucoma Valve implant
American Journal of Ophthalmology · 1995 · 291 citations
Double-masked, randomized, dose-response study of AR-13324 versus latanoprost in patients with elevated intraocular pressure
Ophthalmology · 2015 · First of 6 authors · 116 citations
A review of acquired blepharoptosis: prevalence, diagnosis, and current treatment options
Review · Eye · 2021 · First of 4 authors · Corresponding · 86 citations

DW
David Wirta
7 papers
JL
Jodi Luchs
5 papers
RS
Robert Smyth-Medina
5 papers
JB
Jacob Brubaker
4 papers
SK
Shane Kannarr
4 papers
BS
Barry Schechter
3 papers
JP
James Peace
3 papers
MK
Michael Korenfeld
3 papers
NR
Nathan Radcliffe
3 papers
PK
Paul Karpecki
3 papers
SF
Shane Foster
3 papers
TS
Thomas Samuelson
3 papers

Clinical trials

Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG)
Principal investigator · Completed · Phase 4
Bp Consulting, Inc
2008
A Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular Hypertension
Site PI · Recruiting · Phase 3
YS Life Science Co., Ltd.
2026–2027